Molecularly targeted therapy: Have the floodgates opened?

Brian J. Druker

doi:10.1634/theoncologist.9-4-357

Molecularly targeted therapy: Have the floodgates opened?

Brian J. Druker

Knight Cancer Institute

Research output: Contribution to journal › Comment/debate › peer-review

49 Scopus citations

Original language	English (US)
Pages (from-to)	357-360
Number of pages	4
Journal	Oncologist
Volume	9
Issue number	4
DOIs	https://doi.org/10.1634/theoncologist.9-4-357
State	Published - 2004

Keywords

Chronic myeloid leukemia
Gastrointestinal stromal tumor
Gefitinib
Imatinib
Lung cancer

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1634/theoncologist.9-4-357

Cite this

@article{525ba82bfb7c4782bf522608f90999e0,

title = "Molecularly targeted therapy: Have the floodgates opened?",

keywords = "Chronic myeloid leukemia, Gastrointestinal stromal tumor, Gefitinib, Imatinib, Lung cancer",

author = "Druker, {Brian J.}",

year = "2004",

doi = "10.1634/theoncologist.9-4-357",

language = "English (US)",

volume = "9",

pages = "357--360",

journal = "Oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "4",

}

TY - JOUR

T1 - Molecularly targeted therapy

T2 - Have the floodgates opened?

AU - Druker, Brian J.

PY - 2004

Y1 - 2004

KW - Chronic myeloid leukemia

KW - Gastrointestinal stromal tumor

KW - Gefitinib

KW - Imatinib

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=3543037572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543037572&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.9-4-357

DO - 10.1634/theoncologist.9-4-357

M3 - Comment/debate

C2 - 15266089

AN - SCOPUS:3543037572

SN - 1083-7159

VL - 9

SP - 357

EP - 360

JO - Oncologist

JF - Oncologist

IS - 4

ER -

Molecularly targeted therapy: Have the floodgates opened?

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this